{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:29:23Z","timestamp":1768548563603,"version":"3.49.0"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T00:00:00Z","timestamp":1412726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biochem &amp; Molecular Tox"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Aminoglycoside antibiotics are widely used against Gram\u2010negative infections. On the other hand, nephrotoxicity is a deleterious side effect associated with aminoglycoside therapy. Gentamicin is the most nephrotoxic aminoglycoside. Because of serious health complications ensue the nephrotoxicity induced by aminoglycosides, finding new therapeutic strategies against this problem has a great clinical value. This study has attempted to compare the nephrotoxic properties of gentamicin and a new nanosized formulation of this drug in a mice model. Animals were treated with gentamicin (100 mg\/kg, i.p. for eight consecutive days) and nanogentamicin (100 mg\/kg, i.p. for eight consecutive days). Blood urea nitrogen (BUN), plasma creatinine levels, and histopathological changes of kidney proximal tubule were monitored. It was found that gentamicin caused severe degeneration of kidney proximal tubule cells and an increase in serum creatinine and BUN. No severe injury was observed after nanogentamicin administration. This study proved that nanosized gentamicin is less nephrotoxic.<\/jats:p>","DOI":"10.1002\/jbt.21667","type":"journal-article","created":{"date-parts":[[2014,10,8]],"date-time":"2014-10-08T09:38:02Z","timestamp":1412761082000},"page":"57-62","source":"Crossref","is-referenced-by-count":40,"title":["A Comparison between the Nephrotoxic Profile of Gentamicin and Gentamicin Nanoparticles in Mice"],"prefix":"10.1002","volume":"29","author":[{"given":"Akram","family":"Jamshidzadeh","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz Iran"},{"name":"Pharmacology and Toxicology Department, School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Heidari","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soliman","family":"Mohammadi\u2010Samani","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Azarpira","sequence":"additional","affiliation":[{"name":"Transplant Research Center, School of Medicine Shiraz University of Medical Sciences Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Najbi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center Shiraz University of Medical Sciences Shiraz Iran"},{"name":"Pharmacology and Toxicology Department, School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Jahani","sequence":"additional","affiliation":[{"name":"Pharmacology and Toxicology Department Shiraz University of Medical Sciences International Branch (Kish) Shiraz Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narges","family":"Abdoli","sequence":"additional","affiliation":[{"name":"Ministry of Health Food and Drug Organization Tehran Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1003"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2011.02452.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/138.4.541"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.1.173"},{"issue":"2","key":"e_1_2_6_6_1","first-page":"213","article-title":"Experimental aminoglycoside nephrotoxicity","volume":"86","author":"Luft FC","year":"1975","journal-title":"J Lab Clin Med"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.337"},{"issue":"2","key":"e_1_2_6_8_1","first-page":"212","article-title":"Transport of gentamicin in rat proximal tubule","volume":"48","author":"Wedeen RP","year":"1983","journal-title":"Lab Invest"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860229909085109"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860229509036371"},{"issue":"2","key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1681\/ASN.V92167","article-title":"Aminoglycoside antibiotics traffic to the Golgi complex in LLC\u2010PK1 cells","volume":"9","author":"Sandoval R","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.20"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.5.1663"},{"issue":"3","key":"e_1_2_6_14_1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3565(25)25067-4","article-title":"Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides","volume":"237","author":"Williams PD","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(81)90414-2"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90082-O"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-3-352"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.28.040188.001555"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803030-00002"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2008.12.004"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00339-4"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.08.002"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.2298\/ABS1101157E"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(13)70971-X"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.01.004"},{"issue":"2","key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3565(25)33334-3","article-title":"Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations","volume":"223","author":"Josepovitz C","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2009.09.021"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2004.00247.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01948-4"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2008.07.007"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007090982"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2011.05.050"},{"issue":"1","key":"e_1_2_6_33_1","first-page":"17","article-title":"Anti\u2010bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram\u2010negative and gram\u2010positive bacteria","volume":"2","author":"Azhdarzadeh M","year":"2012","journal-title":"Adv Pharm Bull"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602772"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1203129109"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2001.13.5.461"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2012.03.001"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12005"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0927-7765(99)00058-2"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1088\/1468-6996\/11\/1\/014104"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867311320100004"}],"container-title":["Journal of Biochemical and Molecular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbt.21667","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.21667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T01:57:26Z","timestamp":1746410246000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.21667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1002\/jbt.21667"],"URL":"https:\/\/doi.org\/10.1002\/jbt.21667","archive":["Portico"],"relation":{},"ISSN":["1095-6670","1099-0461"],"issn-type":[{"value":"1095-6670","type":"print"},{"value":"1099-0461","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,8]]}}}